Review
Open access
Aug 2026
Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer
Key approaches targeting DNA repair deficiency, immune regulation, oncogenic signaling pathways, and antigen-directed therapies are highlighted, and their clinical development and application are discussed.
Hui-Fang Cheng, Yanmei Chen, Pei-Yan Liu et al.
· Acta Pharmacologica Sinica · 0 citations